Weak Dollar, Strong Stocks: Altria (MO), Halliburton (HAL), Procter & Gamble (PG), DuPont (DD), IBM (IBM), Chevron (CVX), Dow Chemical (DOW), Exxon Mobil (XOM), Qualcomm (QCOM), Aflac (AFL), Analog Devices (ADI), Colgate-Palmolive (CL), Intel (INTC) and Texas Instruments (TXN)
Although the dollar is weak, Cramer isn't worried, since he doesn't think that interest rates will go up, and he points out that some stocks, especially those which have "incredible" global performance, thrive on a weak dollar. Cramer listed stocks with the lowest U.S. sales including MO, HAL, PG, DD, IBM, CVX, DOW XOM, QCOM, AFL, ADI, CL, INTC, TXN, but cautioned that DOW is an "underperformer," CVX and XOM are "way too levered to oil," tech stocks are "sensitive to consumer spending," and IBM has "already had its move," but may be worth buying when it goes down. However, Cramer discussed his "four horsemen of the weak dollar apocalypse": MO, PG, DD and HAL, all of which should have solid earnings and are worth buying. Altria is "dirt cheap" and its "real value will be unlocked" when it divides into three companies, PG should have an upside surprise from changes in exchange rates and Cramer comments that DuPont "is in a great moment...where price increases are sticking and raw costs are going down." Halliburton should benefit from the weak dollar since it won't have to lower prices.
Related: Altria will not have to give $10 billion tolight cigarette smokers.
Wine is Fine: Constellation Brands (STZ)
Although recent media reports have been hailing the health benefits of red wine, Constellation, the world's leading wine company, has not yet profited from this news. While analysts have made dire predictions, Cramer is not worried about STZ since it is floating "under the radar," but Cramer thinks that it will make a lot of money "now that red wine is virtually a vitamin."
Related: Will Chester is bullish on Constellation Brands.
Bidding Battle: Chemical & Mining Co. of Chile (SQM)
Although Cramer usually tells investors to stay away from "battlegrounds," he would stick with SQM which is in the midst of a bidding war in which both sides are picking up Chemical stock. He likes SQM as a non-medicinal lithium play and because 54% of the company is connected with the fertilizer business which is "the place to be" for growth. In addition, Chemical is "undervalued by 30% based on its earnings alone. "If it gets acquired, the premium should be a whole lot higher than that," Cramer said, and suggests holding SQM but taking some off the table.
Cramer says that HAS and MAT are "incredibly cheap" and explains that a stock is considered inexpensive due to its nature and not "whether it's overbought or oversold." On a side note, Cramer says that he prefers RVBD to PKTR
More: Cramer's latest stock picks, including: Mad Money Recap, Lightening Round, Stop Trading and his Radio Show.
Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.
Seeking Alpha is not affiliated with CNBC, Jim Cramer or TheStreet.com